Determination of the ion collection efficiency of the Razor Nano Chamber for ultra-high dose-rate electron beams.

FLASH radiotherapy dosimetry ion recombination ionization chamber ultra-high dose-rate

Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jul 2022
Historique:
revised: 07 04 2022
received: 11 10 2021
accepted: 12 04 2022
pubmed: 21 4 2022
medline: 20 7 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Ultra-high dose-rate (UHDR) irradiations (>40 Gy/s) have recently garnered interest in radiotherapy (RT) as they can trigger the so-called "FLASH" effect, namely a higher tolerance of normal tissues in comparison with conventional dose rates when a sufficiently high dose is delivered to the tissue. To transfer this to clinical RT treatments, adapted methods and practical tools for online dosimetry need to be developed. Ionization chambers remain the gold standards in RT but the charge recombination effects may be very significant at such high dose rates, limiting the use of some of these dosimeters. The reduction of the sensitive volume size can be an interesting characteristic to reduce such effects. In that context, we have investigated the charge collection behavior of the recent IBA Razor™ Nano Chamber (RNC) in UHDR pulses to evaluate its potential interest for FLASH RT. In order to quantify the RNC ion collection efficiency (ICE), simultaneous dose measurements were performed under UHDR electron beams with dose-rate-independent Gafchromic™ EBT3 films that were used as the dose reference. A dose-per-pulse range from 0.01 to 30 Gy was investigated, varying the source-to-surface distance, the pulse duration (1 and 3 μs investigated) and the LINAC gun grid tension as irradiation parameters. In addition, the RNC measurements were corrected from the inherent beam shot-to-shot variations using an independent current transformer. An empirical logistic model was used to fit the RNC collection efficiency measurements and the results were compared with the Advanced Markus plane parallel ion chamber. The RNC ICE was found to decrease as the dose-per-pulse increases, starting from doses above 0.2 Gy/pulse and down to 40% of efficiency at 30 Gy/pulse. The RNC resulted in a higher ICE for a given dose-per-pulse in comparison with the Markus chamber, with a measured efficiency found higher than 85 and 55% for 1 and 10 Gy/pulse, respectively, whereas the Markus ICE was of 60 and 25% for the same doses. However, the RNC shows a higher sensitivity to the pulse duration than the Advanced Markus chamber, with a lower efficiency found at 1 μs than at 3 μs, suggesting that this chamber could be more sensitive to the dose rate within the pulse. The results confirmed that the small sensitive volume of the RNC ensures higher ICE compared with larger chambers. The RNC was thus found to be a promising online dosimetry tool for FLASH RT and we proposed an ion recombination model to correct its response up to extreme dose-per-pulses of 30 Gy.

Sections du résumé

BACKGROUND BACKGROUND
Ultra-high dose-rate (UHDR) irradiations (>40 Gy/s) have recently garnered interest in radiotherapy (RT) as they can trigger the so-called "FLASH" effect, namely a higher tolerance of normal tissues in comparison with conventional dose rates when a sufficiently high dose is delivered to the tissue. To transfer this to clinical RT treatments, adapted methods and practical tools for online dosimetry need to be developed. Ionization chambers remain the gold standards in RT but the charge recombination effects may be very significant at such high dose rates, limiting the use of some of these dosimeters. The reduction of the sensitive volume size can be an interesting characteristic to reduce such effects.
PURPOSE OBJECTIVE
In that context, we have investigated the charge collection behavior of the recent IBA Razor™ Nano Chamber (RNC) in UHDR pulses to evaluate its potential interest for FLASH RT.
METHODS METHODS
In order to quantify the RNC ion collection efficiency (ICE), simultaneous dose measurements were performed under UHDR electron beams with dose-rate-independent Gafchromic™ EBT3 films that were used as the dose reference. A dose-per-pulse range from 0.01 to 30 Gy was investigated, varying the source-to-surface distance, the pulse duration (1 and 3 μs investigated) and the LINAC gun grid tension as irradiation parameters. In addition, the RNC measurements were corrected from the inherent beam shot-to-shot variations using an independent current transformer. An empirical logistic model was used to fit the RNC collection efficiency measurements and the results were compared with the Advanced Markus plane parallel ion chamber.
RESULTS RESULTS
The RNC ICE was found to decrease as the dose-per-pulse increases, starting from doses above 0.2 Gy/pulse and down to 40% of efficiency at 30 Gy/pulse. The RNC resulted in a higher ICE for a given dose-per-pulse in comparison with the Markus chamber, with a measured efficiency found higher than 85 and 55% for 1 and 10 Gy/pulse, respectively, whereas the Markus ICE was of 60 and 25% for the same doses. However, the RNC shows a higher sensitivity to the pulse duration than the Advanced Markus chamber, with a lower efficiency found at 1 μs than at 3 μs, suggesting that this chamber could be more sensitive to the dose rate within the pulse.
CONCLUSIONS CONCLUSIONS
The results confirmed that the small sensitive volume of the RNC ensures higher ICE compared with larger chambers. The RNC was thus found to be a promising online dosimetry tool for FLASH RT and we proposed an ion recombination model to correct its response up to extreme dose-per-pulses of 30 Gy.

Identifiants

pubmed: 35441716
doi: 10.1002/mp.15675
pmc: PMC9539950
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4731-4742

Informations de copyright

© 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Références

Phys Med Biol. 1998 Aug;43(8):2033-45
pubmed: 9725587
Med Phys. 2012 Jun;39(6):3501-8
pubmed: 22755730
Sci Transl Med. 2014 Jul 16;6(245):245ra93
pubmed: 25031268
Radiother Oncol. 2018 Dec;129(3):582-588
pubmed: 30177374
Med Phys. 2018 Dec;45(12):5608-5621
pubmed: 30294821
Med Phys. 2018 Feb;45(2):863-874
pubmed: 29206287
Radiother Oncol. 2019 Oct;139:18-22
pubmed: 31303340
Sci Rep. 2019 Jul 12;9(1):10132
pubmed: 31300704
Med Phys. 2017 Jun;44(6):2544-2555
pubmed: 28339108
Sci Rep. 2021 May 27;11(1):11242
pubmed: 34045625
Med Phys. 2022 Jul;49(7):4731-4742
pubmed: 35441716
Med Phys. 2017 Mar;44(3):1157-1167
pubmed: 28094853
Sci Rep. 2020 Jun 3;10(1):9089
pubmed: 32493952
Med Phys. 2017 Feb;44(2):725-735
pubmed: 28019660
Br J Radiol. 1950 Oct;23(274):601-11
pubmed: 14777875
Radiother Oncol. 2019 Oct;139:11-17
pubmed: 31253466
Med Phys. 1999 Sep;26(9):1847-70
pubmed: 10505874
Med Phys. 2022 Mar;49(3):1831-1838
pubmed: 35066878
Med Phys. 2015 Feb;42(2):685-93
pubmed: 25652482
Radiother Oncol. 2019 Oct;139:34-39
pubmed: 31174897
Phys Med. 2018 May;49:139-146
pubmed: 28899649
Phys Med. 2016 Apr;32(4):541-56
pubmed: 27020097
Med Phys. 2015 Apr;42(4):1606-13
pubmed: 25832051
Med Phys. 2020 Mar;47(3):1379-1390
pubmed: 31900944
Med Phys. 2021 Jul;48(7):3958-3967
pubmed: 33884618
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):407-415
pubmed: 31010708
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10943-10951
pubmed: 31097580
Phys Med Biol. 2017 Nov 01;62(22):8634-8654
pubmed: 28858855
J Appl Clin Med Phys. 2021 Nov;22(11):165-171
pubmed: 34609051
Cancers (Basel). 2021 Mar 01;13(5):
pubmed: 33804336
Clin Cancer Res. 2019 Jan 1;25(1):3-5
pubmed: 30093447
Sci Rep. 2021 Mar 12;11(1):5844
pubmed: 33712653
Z Med Phys. 2004;14(4):260-6
pubmed: 15656108
Phys Med Biol. 2000 Jul;45(7):1781-805
pubmed: 10943919
Radiother Oncol. 2022 Sep;174:87-91
pubmed: 34998899
Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):819-829
pubmed: 33075474
Radiother Oncol. 2017 Sep;124(3):365-369
pubmed: 28545957
Sci Rep. 2020 Oct 14;10(1):17307
pubmed: 33057078
Phys Med. 2020 Dec;80:134-150
pubmed: 33181444
Phys Med. 2017 Oct;42:327-331
pubmed: 28506453
Sci Rep. 2019 Jul 25;9(1):10837
pubmed: 31346184
Clin Cancer Res. 2019 Jan 1;25(1):35-42
pubmed: 29875213
Cancers (Basel). 2021 Sep 30;13(19):
pubmed: 34638424
Med Phys. 2012 May;39(5):2447-55
pubmed: 22559615
Phys Med Biol. 1996 May;41(5):885-97
pubmed: 8735255
Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):440-448
pubmed: 31928642
Phys Med. 2013 Nov;29(6):599-606
pubmed: 23107430
Med Phys. 2005 Jul;32(7Part1):2204-2210
pubmed: 28493588
Radiother Oncol. 2019 Oct;139:28-33
pubmed: 31178058
Med Phys. 2020 Dec;47(12):5986-6025
pubmed: 32990328

Auteurs

Marco Cavallone (M)

Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre Universitaire, 91898 Orsay, France.
Laboratoire d'Optique Appliquée, ENSTA Paris, École Polytechnique, CNRS-UMR7639, Institut Polytechnique de Paris, 91762 Palaiseau Cedex, France.

Patrik Gonçalves Jorge (P)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Rue du Grand-Pré 1, Switzerland.

Raphaël Moeckli (R)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Rue du Grand-Pré 1, Switzerland.

Claude Bailat (C)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Rue du Grand-Pré 1, Switzerland.

Alessandro Flacco (A)

Laboratoire d'Optique Appliquée, ENSTA Paris, École Polytechnique, CNRS-UMR7639, Institut Polytechnique de Paris, 91762 Palaiseau Cedex, France.

Yolanda Prezado (Y)

Institut Curie, Université PSL, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400 Orsay, France.
Université Paris-Saclay, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400 Orsay, France.

Rachel Delorme (R)

University of Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France.
Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), CNRS Univ Paris-Sud, Université Paris-Saclay, 91400 Orsay, France.

Articles similaires

Humans Female Precision Medicine Radiotherapy Planning, Computer-Assisted Breast Neoplasms
Humans Proton Therapy Lung Neoplasms Radiotherapy Planning, Computer-Assisted Radiotherapy, Intensity-Modulated
In Situ Hybridization, Fluorescence Humans Chromosome Aberrations Radiometry Marine Toxins
Nitrogen Wastewater Sulfur Carbon Bioreactors

Classifications MeSH